A new independent publication confirms that masitinib has anti-viral activity against the SARS-CoV-2 virus in vitro
25/01/2021 – AB Science announces that a new independent publication confirms that masitinib has anti-viral activity against the SARS-CoV-2 virus in vitro and is a promising candidate for treating Covid-19